Librachrom

Sodium cromoglicate, the active ingredient in Librachrom, is a mast cell stabilizer presented as an ophthalmic solution for ocular use. It is employed to manage allergic conjunctivitis and other mast cell‑mediated eye inflammation, and is indicated for patients with seasonal or perennial ocular allergy symptoms requiring topical therapy.

GNH USA supplies Librachrom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance, and reliable logistics solutions for global distribution.

Librachrom, containing sodium cromoglicate, is used to treat ocular conditions driven by mast cell activation and allergic pathways.

Allergic conjunctivitis: reduces itching, redness, tearing and swelling associated with allergic eye disease. Mast cell‑mediated ocular inflammation: stabilizes ocular mast cells to prevent release of histamine and inflammatory mediators. Seasonal allergic eye disease: provides relief of symptoms during pollen or allergen exposure periods.

Adverse ocular reactions have been reported with topical sodium cromoglicate, although most are mild and transient.

Common Side Effects: - Transient burning or stinging sensation upon instillation. - Temporary blurred vision. - Mild conjunctival redness.

Serious or Rare Side Effects: - Allergic contact dermatitis of the eyelid or peri‑ocular skin. - Severe ocular inflammation or keratitis. - Corneal ulceration or vision loss.

When using Librachrom, certain precautions should be observed to ensure safety and optimal therapeutic outcome.

Pregnancy: consult a healthcare professional before use. Breastfeeding: discuss potential risks with a physician. Concurrent ocular infection: avoid use until infection is resolved. Contact lens wearers: remove lenses before instillation and wait several minutes before reinserting. Use with other ocular medications: space dosing by at least five minutes to prevent dilution. Store at ambient temperature: keep in the original container, protect from light and moisture.

Librachrom may interact with other ophthalmic agents; awareness of potential interactions helps maintain efficacy and safety.

Major Interactions (Avoid): - Concurrent use of topical ocular anesthetics: may increase corneal toxicity. - Combination with other mast cell stabilizers: no added therapeutic benefit.

Moderate Interactions (Monitor Closely): - Use with corticosteroid eye drops: monitor intraocular pressure. - Use with non‑steroidal anti‑inflammatory eye drops: observe for increased irritation. - Use with contact lens solutions: ensure compatibility to avoid lens damage.